CIS
BLUE

Capital International Sarl’s bluebird bio BLUE Stock Holding History

Capital International Sarl’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed -$5K – 212
2020
Q1 		$5K Hold
8
– – ﹤0.01% 227
2019
Q4 		$9K Sell
8
-1,712
-100% -$1.86M ﹤0.01% 176
2019
Q3 		$2.05M Sell
1,720
-680
-28% -$1.04M 0.35% 85
2019
Q2 		$3.95M Sell
2,400
-154
-6% -$266K 0.55% 63
2019
Q1 		$5.21M Sell
2,554
-903
-26% -$1.59M 0.65% 49
2018
Q4 		$4.44M Buy
3,457
+485
+16% +$744K 0.53% 63
2018
Q3 		$5.62M Buy
2,972
+1,055
+55% +$2.18M 0.54% 63
2018
Q2 		$3.9M Buy
1,917
+467
+32% +$1.06M 0.39% 76
2018
Q1 		$3.21M Buy
+1,450
New +$3.69M 0.31% 88

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Sarl's BLUE Position: Q2 2020 in Review

Capital International Sarl sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 8 shares — an estimated $5K sold.

Capital International Sarl first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $5.62M in Q3 2018. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

  • Capital International Sarl reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
  • Capital International Sarl sold 8 bluebird bio shares in Q2 2020, an estimated $5K.
  • Capital International Sarl first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
  • Capital International Sarl's bluebird bio position peaked at $5.62M in Q3 2018.
  • 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Capital International Sarl's 13F filing for Q2 2020, filed 14 Aug 2020.